# Smith & Nephew plc Improved underlying revenue growth

- Link: https://www.directorstalkinterviews.com/smith-nephew-plc-improved-underlying-revenue-growth/412760708
- Published: 2018-11-01T07:51:17+00:00
- Author: Charlotte Edwards

**Smith & Nephew plc** (LON:SN, NYSE:SNN), the global medical technology business,
announced its trading report for the third quarter ended 29 September 2018.

> **Namal Nawana, Chief Executive Officer of Smith & Nephew, said:**
> “Improved underlying revenue growth in the third quarter was led by growth in 
> the US and Emerging Markets. We are on-track to deliver our full year guidance.
> “These results were achieved whilst successfully redesigning how we will run the
> company. There is still more to do, and I am pleased with the pace of progress
> and engagement across the organisation.”

**Q3 Highlights1,2**

· Q3 revenue $1,169 million, up 2% on a reported and 3% on an underlying basis

· Underlying revenue growth of 4% in the US, and 10% in the Emerging Markets

· Strong growth in Reconstruction, Sports Medicine Joint Repair and Advanced Wound
Devices

· Advanced Wound Bioactives continued to decline

· Full year guidance reconfirmed

· Moving to new global commercial structure to unlock value through specialist global
franchises

Share on: